Related Experiment Videos

Patient-Reported Outcome Design and Analysis in Randomized Controlled Trials of Renal Cell Carcinoma: A Systematic

David Chen1, Sherry Chen2, Daisy Sun2

  • 1Radiation Medicine Program, Princess Margaret Hospital Cancer Centre, Toronto, Ontario, Canada; Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Radiation Oncology, Department of Surgery, University of British Columbia, Vancouver, Ontario, Canada.

Summary

Patient-reported outcomes (PROs) are collected in renal cell carcinoma (RCC) trials, but their reporting lacks consistency. Improved prospective planning and transparent reporting in trial registrations, protocols, and publications are needed for clinical utility.